Bioequivalence & Bioavailability International Journal (BEBA)

Bioequivalence & Bioavailability International Journal (BEBA) is specifically designed to provide researchers around the world in the field of Bioequivalence & Bioavailability. We invites authors to submit their original articles, reviews, opinions, clinical perspectives, short communications, case reports, news, proceedings, health policies etc., where BEBA provides complete information for practitioners concerned with topics in the field of Bioequivalence and Bioavailability like Biosimilars, FDA Bioequivalence, Bioequivalence antipsychotics and many other interesting research. This journal acts as a platform for researchers to share their research work to world. The scope of the journal is to provide an international opportunity for encouraging noble discussions and thus contributing the best understanding of Bioequivalence & Bioavailability & benefiting readers, authors by accelerating the dissemination of research information provides maximum access to the advanced current academic and clinical information of the god finest architecture.

Bioequivalence & Bioavailability International Journal (BEBA) is :-

• International, Peer-Reviewed, Open Access, Refereed, Bioequivalence, Bioavailability, Clinical Pharmacology, Biosimilars, FDA Bioequivalence, Pharmacokinetics, Drug Development, Therapeutics , Online , Bi-Annual Journal

• UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2578-4803, Established: 2017, Impact Factor: 4.124
• Provides Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE